Endeavor Health
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Endeavor Health sits in the top decile of US sponsors by registered trial count (#250 of 15,742 sponsors by registered trial count).
Endeavor Health: 94 sponsored US clinical trials, 19 recruiting.
Endeavor Health sponsors 94 registered US clinical trials on ClinicalTrials.gov, 19 of them currently recruiting, and 54 completed. 25 of these trials are in Phase 3-4 (later-stage) and 12 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Heart Failure, with 2 trials.
Top-decile sponsor footprint
Endeavor Health ranks in the top decile of sponsors by registered trial count (#250 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
54 of 68 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (79.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
94 total, page 1 of 2
Zinc Supplementation With Botulinum Toxin for Overactive Bladder
NCT07405554
Improving Safety, Patient Experience and Equity Through Shared Decision-making Huddles in Labor
NCT06828406
NSAID Use for Treating Dysmenorrhea and Preventing Chronic Pelvic Pain (NSAID HEAL)
NCT06861920
Postpartum Ultrasound Evaluation to Assess Risk of Hemorrhage
NCT06898034
Prenatal Sonographic Prediction of Placental Histology and Function
NCT06022458
Beyond MARS: Magnetic Resonance Study: A Novel Assessment of Placental Perfusion During Pregnancy
NCT06314009
Effects of TNF Blockade on Human BPH/LUTS
NCT06062875
Non Inferiority Trial Investigating Surfactants Administered Via MIST
NCT06074380
Prophylactic Minimally Invasive Surfactant Evaluation
NCT06007547
Using Placental Pathology to Prevent Recurrent Adverse Pregnancy Outcomes: A Pilot Project
NCT06004674
IVIG in the Treatment of Autoimmune Small Fiber Neuropathy With TS-HDS, FGFR-3, or Plexin D1 Antibodies
NCT04153422
Reducing Postoperative Opioids in Patients Undergoing Laparoscopic Hiatal Hernia
NCT05953428
Efficacy of Azelastine and Mometasone Irrigation in Comparison to Nasal Sprays in Patients With Chronic Rhinitis
NCT05626621
Furthering Equity Through Infant Feeding EDucation and Support
NCT05441709
Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy
NCT05295407
Long Term Outcomes Following Hernia Repair With Mesh
NCT04578340
Methadone and Quality of Postoperative Recovery
NCT03168958
Intra-articular Platelet-Rich Plasma Compared With Viscosupplementation in the Treatment of Knee Osteoarthritis
NCT03491761
Effect of Methadone and Hydromorphone on the QT Interval After Anesthesia and Surgery
NCT03893734
Paired-Ring Mitral Annuloplasty Ring Sizing Device
NCT06965725
Evaluating Outcomes in Cardiac Surgery Patients Who Receive Sugammadex vs. Placebo
NCT05801679
Quality of Recovery From Mastectomy With and Without PECS Blocks
NCT05795413
Fasenra: An Asthma Study
NCT07654842
Aprepitant to Improve Same Day Discharge for TKA
NCT07639723
Autonomic Neural Blockade in Bariatric Surgery
NCT07104825
Effect of Tizanidine on Postoperative Urinary Retention After Sacrospinous Suspension
NCT06258785
Fasting Mimicking Diet (FMD) in Conjunction With Chemotherapy in Advanced Ovarian Cancer
NCT05921149
Prospective Randomized Controlled Trial of Obstructed Defecation Surgery
NCT05747027
Splint Users' Satisfaction and Functional Status With Custom Finger Splints
NCT05903391
Effect of Preoperative Tamsulosin on Postoperative Urinary Retention
NCT05753670
Care Companion Diabetes
NCT05548218
IC PaIN Trial: Interstitial Cystitis Pain Improvement With Naltrexone
NCT04313972
The Cascade Feasibility Pilot (Ileostomy)
NCT05048329
Supporting Women With Breast Cancer to Prepare for Treatment (The Prepare Study)
NCT07221071
The Cascade Feasibility Pilot (HF) Phase 3
NCT04993287
Advanced Diffusion Tensor MRI for Breast Cancer
NCT04774471
The CASCADE HF Soft Launch and Calibration Phase I and II
NCT04738279
Performance and Safety of a Novel Ostomy Ring to Improve Ileostomy and Colostomy Management
NCT04802538
Mechanistic Characterization of Uterine Pain
NCT04145518
Intraoperative Methadone for Postoperative Pain Control After Thoracic Surgery
NCT04525898
How Variations in Pharmacogenomic Profiles Affect Pain and Narcotic Needs Following Total Knee Arthroplasty (TKA)
NCT04020471
Electromyographic Monitoring and Postoperative Recovery
NCT03891381
One Key Question: Pilot Study at NorthShore
NCT03947788
MARS: Magnetic Resonance Study: A Novel Assessment of Placental Function
NCT03764878
The MEDITATE-BC Study: Mindfulness-Enhanced Decision Intervention To Aid Treatment Election - Breast Cancer
NCT03880799
A RCT of CenteringPregnancy on Birth Outcomes and Maternal Inflammation
NCT04097548
Examining the Role of Improved NSAID Management in Treating Dysmenorrhea and Bladder Pain
NCT03697720
The Use of the Propeller Health Platform to Improve Inhaled Corticosteroid (ICS) Use Among Adults With Uncontrolled Persistent Asthma
NCT03860519
Tissue Adhesive vs. Sterile Strips After Cesarean Delivery
NCT02838017
Protocol for Admission Toxigenic C. Difficile Surveillance
NCT04014608
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 11 |
| Phase 3 | 3 |
| Phase 4 | 22 |
Where Endeavor Health enrollment is open (later-stage tilt)
19 recruiting of 94 indexed (20% open); 54 completed (57%).
Phase mix: 25 late (III/IV) vs 12 early (I/II) (later-stage heavy).
Top condition: Heart Failure (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Endeavor Health: open-pipeline peers nationwide
Peers matched on 94 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
Endeavor Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 94 trials (± recruiting share)
- Colorado State University · 94 trials · 21% recruiting
- National Center for Research Resources (NCRR) · 94 trials · 0% recruiting
- AdventHealth · 95 trials · 17% recruiting
- Texas A&M University · 95 trials · 23% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Florida International University · 20% recruiting · 89 trials
- University of Houston · 20% recruiting · 64 trials
- University of Miami · 20% recruiting · 721 trials
- University of California, Irvine · 20% recruiting · 368 trials
Related
What to do with this Endeavor Health page
94 registered trials is a research-attention snapshot, not an endorsement of Endeavor Health or any single study.
- 19 of Endeavor Health's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Heart Failure is the condition Endeavor Health studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Heart Failure trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Endeavor Health pipeline card: 94 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.